AMERICAN VANGUARD CORP (AVD) Stock Fundamental Analysis
NYSE:AVD - New York Stock Exchange, Inc. - US0303711081 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to AVD. AVD was compared to 85 industry peers in the Chemicals industry. AVD may be in some trouble as it scores bad on both profitability and health. AVD has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
AVD had negative earnings in the past year.
AVD had a positive operating cash flow in the past year.
Of the past 5 years AVD 4 years were profitable.
AVD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
AVD's Return On Assets of -21.59% is on the low side compared to the rest of the industry. AVD is outperformed by 82.35% of its industry peers.
Looking at the Return On Equity, with a value of -59.97%, AVD is doing worse than 83.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.59% | ||
| ROE | -59.97% | ||
| ROIC | N/A |
ROA(3y)-5.03%
ROA(5y)-2.04%
ROE(3y)-14.92%
ROE(5y)-7.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AVD has a Gross Margin of 20.47%. This is in the lower half of the industry: AVD underperforms 67.06% of its industry peers.
AVD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AVD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.88%
GM growth 5Y-10.32%
2. Health
2.1 Basic Checks
AVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVD has more shares outstanding
The number of shares outstanding for AVD has been reduced compared to 5 years ago.
Compared to 1 year ago, AVD has a worse debt to assets ratio.
2.2 Solvency
AVD has an Altman-Z score of 1.53. This is a bad value and indicates that AVD is not financially healthy and even has some risk of bankruptcy.
AVD has a worse Altman-Z score (1.53) than 65.88% of its industry peers.
AVD has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as AVD would need 7.90 years to pay back of all of its debts.
AVD has a better Debt to FCF ratio (7.90) than 68.24% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that AVD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, AVD is in line with its industry, outperforming 47.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 1.53 |
ROIC/WACCN/A
WACC9.3%
2.3 Liquidity
AVD has a Current Ratio of 1.77. This is a normal value and indicates that AVD is financially healthy and should not expect problems in meeting its short term obligations.
AVD's Current ratio of 1.77 is in line compared to the rest of the industry. AVD outperforms 41.18% of its industry peers.
AVD has a Quick Ratio of 1.77. This is a bad value and indicates that AVD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.91, AVD is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.77 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
AVD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1336.00%.
AVD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.46%.
The Revenue has been growing slightly by 3.17% on average over the past years.
EPS 1Y (TTM)-1336%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)-10.46%
Revenue growth 3Y-0.58%
Revenue growth 5Y3.17%
Sales Q2Q%-14.31%
3.2 Future
Based on estimates for the next years, AVD will show a very strong growth in Earnings Per Share. The EPS will grow by 46.18% on average per year.
Based on estimates for the next years, AVD will show a small growth in Revenue. The Revenue will grow by 0.27% on average per year.
EPS Next Y97.41%
EPS Next 2Y46.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.9%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AVD. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 11.27, the valuation of AVD can be described as very reasonable.
Based on the Price/Forward Earnings ratio, AVD is valued a bit cheaper than the industry average as 74.12% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AVD to the average of the S&P500 Index (36.21), we can say AVD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.27 |
4.2 Price Multiples
94.12% of the companies in the same industry are more expensive than AVD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.6 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AVD's earnings are expected to grow with 46.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
AVD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.21
+0.35 (+9.07%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners72.47%
Inst Owner Change-0.44%
Ins Owners8.4%
Ins Owner Change0.08%
Market Cap118.85M
Analysts80
Price Target12.24 (190.74%)
Short Float %3.55%
Short Ratio4.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.09
Dividend Growth(5Y)2.42%
DP-1.23%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-571.08%
Min EPS beat(2)-817.82%
Max EPS beat(2)-324.33%
EPS beat(4)0
Avg EPS beat(4)-706.27%
Min EPS beat(4)-858.83%
Max EPS beat(4)-324.33%
EPS beat(8)0
Avg EPS beat(8)-388.77%
EPS beat(12)2
Avg EPS beat(12)-259.72%
EPS beat(16)5
Avg EPS beat(16)-187.95%
Revenue beat(2)0
Avg Revenue beat(2)-6.62%
Min Revenue beat(2)-9.72%
Max Revenue beat(2)-3.53%
Revenue beat(4)0
Avg Revenue beat(4)-8.52%
Min Revenue beat(4)-15.85%
Max Revenue beat(4)-3.53%
Revenue beat(8)0
Avg Revenue beat(8)-8.01%
Revenue beat(12)0
Avg Revenue beat(12)-7.76%
Revenue beat(16)4
Avg Revenue beat(16)-3.2%
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)-83.33%
EPS NQ rev (3m)-650%
EPS NY rev (1m)0%
EPS NY rev (3m)-133.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.27 | ||
| P/S | 0.23 | ||
| P/FCF | 5.6 | ||
| P/OCF | 4.61 | ||
| P/B | 0.52 | ||
| P/tB | 2 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.09
EYN/A
EPS(NY)0.37
Fwd EY8.88%
FCF(TTM)0.75
FCFY17.85%
OCF(TTM)0.91
OCFY21.68%
SpS18.7
BVpS8.05
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.59% | ||
| ROE | -59.97% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.47% | ||
| FCFM | 4.02% |
ROA(3y)-5.03%
ROA(5y)-2.04%
ROE(3y)-14.92%
ROE(5y)-7.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.88%
GM growth 5Y-10.32%
F-Score3
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 21.07% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.77 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.53 |
F-Score3
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)51.85%
Cap/Depr(5y)55.48%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1336%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y97.41%
EPS Next 2Y46.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.46%
Revenue growth 3Y-0.58%
Revenue growth 5Y3.17%
Sales Q2Q%-14.31%
Revenue Next Year-2.9%
Revenue Next 2Y0.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-246.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year346.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.29%
OCF growth 3Y-64.32%
OCF growth 5Y-16.03%